Laboratory and virology
Preliminary review of D222G amino acid substitution in the haemagglutinin of pandemic influenza A (H1N1) 2009 viruses
28 December 2009
Laboratory biorisk management for laboratories handling human specimens suspected or confirmed to contain influenza A (H1N1) causing the current international epidemics
30 November 2009
WHO information for laboratory diagnosis of pandemic (H1N1) 2009 virus in humans - revised
23 November 2009
Summary of available potency testing reagents for Pandemic (H1N1) 2009 virus vaccines
20 November 2009
Instructions for transport of virus cultures (i.e. virus isolates) of candidate reassortant vaccine viruses of pandemic (H1N1) 2009 virus
27 July 2009
Update of WHO biosafety risk assessment and guidelines for the production and quality control of human influenza pandemic vaccines
28 May 2009
Characteristics of the emergent influenza A (H1N1) viruses and recommendations for vaccine development
26 May 2009
Instructions for storage and transport of suspected or confirmed human and animal specimens and virus isolates of pandemic (H1N1) 2009
20 May 2009
Protocol for antiviral susceptibility testing by pyrosequencing
13 May 2009
Sequencing primers and protocol
12 May 2009
Status of candidate vaccine virus development for the current Influenza A(H1N1) virus
9 May 2009
Countries able to perform PCR to diagnose influenza A (H1N1) virus infection in humans
7 May 2009
Instruction on how to obtain CDC realtime RT-PCR kits for detection of influenza A(H1N1)
2 May 2009
CDC protocol of realtime RTPCR for influenza A (H1N1)
30 April 2009
Instructions for shipments of pandemic (H1N1) 2009 specimens and virus isolates to WHO Collaborating Centres for influenza
28 April 2009
Viral gene sequences to assist update diagnostics for influenza A (H1N1) - GenBank accession numbers
28 April 2009
Viral gene sequences to assist update diagnostics for influenza A (H1N1)
25 April 2009
|
